The MPN Research Foundation has an exciting announcement to make! This fall, in collaboration with MPN Advocacy & Education International, The Leukemia and Lymphoma Society, and UT Health San Antonio MD Anderson Cancer Center, MPNRF will be holding an externally led patient-focused drug development (PFDD) meeting with the Food and Drug Administration (FDA).
This meeting is a long-awaited opportunity for the MPN community to stand in front of decision makers like FDA regulators, academic researchers, and industry players to convey the challenges that ET, PV, and MF patients face every day. Our objective is to give MPN patients a platform so that they can share with the world what it means to have an MPN diagnosis, which of their symptoms should be prioritized, and how their disease impacts their quality of life.
Advocacy initiatives like these are very important, and they take an immense amount of resources. Will you support our work by making a gift today? We are proud to be a voice for MPN patients around the world and we know the generosity of individuals like you will make us stronger!